A Point Biopharma Global cancer therapy key to a $1.4 billion Eli Lilly M&A deal has met the main goal of its pivotal clinical trial in prostate cancer. But the results raise questions about how well ...
A targeted radiation drug being developed by Indianapolis-based Point BioPharma met its goal in a late-stage prostate cancer study, but fell short of analyst expectations for a greater treatment ...
PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- During September's Prostate Cancer Awareness Month, MidLantic Urology wants to stress an important point—0.75. If your prostate-specific antigen (PSA) level ...
Two proteins that act in opposing directions -- one that promotes cancer and one that suppresses cancer -- regulate the same set of genes in prostate cancer, researchers have found. Two proteins that ...
Charlie Wilson, Jean Fogelberg and Rosey Grier Join “Advance on Washington” to Improve Treatments, Reduce Overtreatment WASHINGTON--(BUSINESS WIRE)-- With $3 billion spent on the over-treatment of ...
Prostate cancer is absurdly common, but many men are mum about it. Joe Biden’s diagnosis has focused public attention on it. Good morning. I’m Mark Shanahan, guest-writing Starting Point to tell you ...
Studies have shown that disruptions in circadian rhythms caused by chronic sleep deprivation and other lifestyle-related issues are linked to an increased incidence of some cancers, including prostate ...
CHICAGO (Reuters) - US researchers have found a way to pinpoint where in the prostate a tumor may be hiding by using an imaging technique that measures the chemical composition of tissues. Although ...
Scientists have identified a gene that puts men at high risk of developing prostate cancer. The gene, which runs in families, appears to roughly double the risk of the disease, researchers at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback